Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F11 | P03951 | 19/20 | 0.59 |
| ▸ | KLKB1 | P03952 | 6/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.40 |
| ▸ | KLK1 | P06870 | 2/20 | 0.40 |
| ▸ | PLAT | P00750 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 2/20 | 0.38 |
| ▸ | F12 | P00748 | 2/20 | 0.38 |
| ▸ | F7 | P08709 | 2/20 | 0.38 |
| ▸ | PLG | P00747 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12011712 | 0.91 | F11 (0.62) | F11KLKB1PRSS1PRSS2PRSS3 | |
| SCHEMBL1922355 | 0.87 | F11 (0.58) | F11KLKB1PRSS1PRSS2PRSS3 | |
| SCHEMBL1922357 | 0.87 | F11 (0.58) | F11KLKB1PRSS1PRSS2PRSS3 | |
| SCHEMBL1196721 | 0.87 | F11 (0.77) | F11KLKB1KLK1PLATF10 | |
| SCHEMBL1196720 | 0.87 | F11 (0.77) | F11KLKB1KLK1PLATF10 | |
| SCHEMBL1920992 | 0.84 | F11 (0.57) | F11KLKB1PRSS1PRSS2PRSS3 | |
| SCHEMBL1921123 | 0.84 | F11 (0.55) | F11KLKB1PRSS1PRSS2PRSS3 | |
| SCHEMBL1921124 | 0.84 | F11 (0.55) | F11KLKB1PRSS1PRSS2PRSS3 | |
| SCHEMBL12011717 | 0.84 | F11 (0.55) | F11KLKB1PRSS1PRSS2PRSS3 | |
| SCHEMBL8241649 | 0.83 | F11 (0.62) | F11KLKB1PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1981854-B1 | ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2011-06-01 | — | — | EP | claimed |